P/S-Lipoprotein(a)
Senast uppdaterad: Senast reviderad:
Sakkunnig:Anders Kallner
- Nilsson-Ehrle P, Berggren Söderlund M, Theodorsson E et al (red). Laurells Klinisk kemi i praktisk medicin. Lund: Studentlitteratur, 2012.
- Karolinska universitetslaboratoriet
- Labmedicin Skåne
- Kamstrup PR, Tybjaerg-Hansen A, Steffensen R, Nordestgaard BG. Genetically elevated lipoprotein(a) and increased risk of myocardial infarction. JAMA 2009; 301: 2331-9. Journal of the American Medical Association
- Kamstrup PR. Lipoprotein(a) and ischemic heart disease--a causal association? A review. Atherosclerosis 2010; 211: 15-23. PubMed
- Nordestgaard BG, Chapman MJ, Ray K, Boren J, Andreotti F, Watts GF, et al. Lipoprotein(a) as a cardiovascular risk factor: current status. Eur Heart J 2010; 31: 2844-53. European Heart Journal
- Erqou S, Kaptoge S, Perry PL, Di Angelantonio E, Thompson A, White IR, et al. Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality. JAMA 2009; 302: 412-423. Journal of the American Medical Association
- Trinder M, Paruchuri K, Haidermota S, et al. Repeat Measures of Lipoprotein(a) Molar Concentration and Cardiovascular Risk. J Am Coll Cardiol 2022. pmid:35177190 PubMed
- Anders Kallner, docent och fd överläkare, Karolinska universitetslaboratoriet, Karolinska universitetssjukhuset